News

More November EMA/CHMP recommendations

22-11-2014

A total of 10 new medicines have been recommended for approval at the November 2014 meeting of the European…

apremilastBoehringer IngelheimCelgene Corp.DermatologicalsEuropeNephrology and HepatologyNeurologicalnintedanibOfevOtezlaPharmaceuticalRasagilineRegulationRespiratory and PulmonarySanofiShionogiTeva Pharmaceutcal Industries

Promethera raises 23.6 million euros, with backers including Shire and Boehringer

28-03-2012

Belgian cell therapy company Promethera Biosciences yesterday completed a fundraising round that generated…

BiotechnologyBoehringer IngelheimFinancialHepaStemNephrology and HepatologyPromethera BiosciencesRegulationShire

Back to top